Table 2 Patients’ treatment and in-hospital outcomes
Characteristic in median ± IQR unless otherwise stated | Patients received BCPAP (N= 16 unless otherwise stated) | Patients did not receive BCPAP (N= 43 unless otherwise stated) |
|---|---|---|
Treatment prehospital | Â | Â |
Furosemide, % | 100 | 63 (N = 37) |
GTN sublingually, % | 88 (N = 15) | 47 (N = 34) |
Intubation, % | 0 | 0 (N = 39) |
In-hospital outcomes | Â | Â |
Pulse oximetry, % | 95 ± 11 | 95 ± 7 (N = 38) |
Heart rate, beats/min | 114 ± 35 | 98 ± 33 |
Systolic blood pressure, mmHg | 160 ± 40 | 151 ± 49 (N = 41) |
Diastolic blood pressure, mmHg | 86 ± 19 | 80 ± 33 (N = 41) |
O2 content first ABG, % | 97 ± 6 | 96 ± 6 (N = 29) |
paCO2 in first ABG, kPa | 6.2 ± 2.8 | 5.9 ± 2.1 (N = 29) |
paO2 in first ABG, kPa | 12.1 ± 20 | 11.3 ± 4.2 (N = 29) |
pH in first ABG | 7.3 ± 0.1 | 7.3 ± 0.1 (N = 29) |
Intubation, % | 6.3 | 7.0 (N = 41) |
Admission to ICU, % | 6.3 | 12 (N = 42) |
Length of stay ICU, hours | 53 (N = 1) | 24 ± 196 (N = 5) |
Admission CCU, % | 88 | 54 (N = 42) |
Length of stay CCU, hours | 23 ± 13 (N = 14) | 23 ±32 (N = 22) |
Length of stay total, days | 4.6 ± 3.9 (N = 15) | 5.1 ±7.3 (N = 39) |
In-hospital mortality,% | 12.5 | 9.3 |